BREEMAX-F-400 INHALER
MRP: 510
Packaging: 120 MD
Pack Type: inhaler
Composition:
Budesonide 400mg + Formoterol Fumarate Dihydrate 6mg
Indication:
Increases Lung Function And Improves Asthma Control, Reduces Day/light-time Symptoms And Asthma Exacerbations
Description:
This formulation combines Budesonide 400mcg, an inhaled corticosteroid (ICS), with Formoterol Fumarate Dihydrate 6mcg, a long-acting beta-2 agonist (LABA), to offer powerful maintenance therapy for moderate to severe asthma and chronic obstructive pulmonary disease (COPD).
Budesonide reduces airway inflammation and prevents exacerbations.
Formoterol provides rapid and sustained bronchodilation for easier breathing.
This lower-strength LABA dose (6mcg) with a higher ICS dose (400mcg) is especially suited for patients who require greater anti-inflammatory control with minimal systemic side effects.
Tags:
- Dual-action asthma/COPD control
- High anti-inflammatory effect with Budesonide 400mcg
- Long-lasting bronchodilation via Formoterol
- Reduces frequency and severity of attacks
- Convenient once/twice daily dosing
Usage Information
Dosage
Adults: 1-2 inhalations twice daily, or as prescribed Use device correctly with proper technique Rinse mouth after use Do not exceed recommended dosage Continue use even if symptoms improve (maintenance therapy)
Side Effects
Oral candidiasis (thrush) Hoarseness, sore throat Palpitations, muscle cramps Headache, tremor Rare: paradoxical bronchospasm
Contraindications
Hypersensitivity to Budesonide, Formoterol, or excipients Acute episodes of asthma requiring rapid relief Caution in patients with cardiovascular disorders, thyroid dysfunction, or diabetes Do not abruptly discontinue therapy
Availability
budesonide 400mcg formoterol 6mcg inhaler budesonide formoterol DPI ICS LABA combination inhaler formoterol fumarate dihydrate inhaler asthma controller medication budesonide 400 formoterol 6 COPD treatment maintenance inhaler for asthma steroid bronchodilator inhaler